Category Archives: Life Sciences

JLL Announced as Leasing Agent for University of Delaware’s STAR Tower

June 5, 20170 CommentBy JLL Philadelphia

In case you missed it, JLL and Delle Donne and Associates have formally announced the development of a new trophy office tower at The University of Delaware’s Science, Technology and Advanced Research (STAR) Campus. Since renderings began circulating and… Read More

A Valuable Real Estate Partner in Philadelphia’s Booming Economy

March 8, 20160 CommentBy JLL Philadelphia

It’s an exciting time for Philadelphia, and no firm knows that better than us.

“There’s a real buzz here,” says Mike McCurdy, managing director of the Philadelphia market. “Cranes are everywhere, and new retailers are coming in. Millennials through Baby Boomers are moving downtown, while key suburban markets remain strong. It’s the best economy I’ve seen in my 30-year real estate career here.”

Why here? Why now?

Philadelphia has historically maintained a fairly stable economy—never… Read More

Where Philadelphia ranks among the nation’s top life sciences clusters: Philadelphia Business Journal

August 28, 20150 CommentBy JLL Philadelphia

life-sciences-cluster

Philadelphia once again grabbed the seventh place ranking on JLL’s list of the top life sciences clusters in the United States.

Its annual life sciences cluster rankings take into account, in order of importance, a region’s percentage of employees in the life sciences, venture capital funding, National Institutes of Health funding, life sciences patents, percentage of… Read More

Four key trends that have shifted the way in which life sciences firms conduct business

August 17, 20150 CommentBy JLL Philadelphia

JLL’s annual Life Sciences Outlook, released in July, tracks geographic shifts in life sciences innovation, operations and facilities investments, including analysis of countries and cities most actively investing in their life sciences sectors. It includes a ranking of the top U.S. life sciences clusters – in which Philadelphia ranks seventh.

“In their U.S. operations, biopharmaceutical companies are being squeezed by rising costs for highly trained talent, more expensive real estate markets and… Read More

Commercial insights, trends and news from JLL's Philadelphia team